Press release
Generalized Anxiety Disorder Market Size, Share, Trends Analysis Report 2024 | Growth Analysis By TBRC
The Business Research Company's Generalized Anxiety Disorder Global Market Report 2024 identifies the rising number of mental disorder cases in the healthcare industry is driving the growth of the generalized anxiety disorder market. A mental disorder, also known as a mental illness, refers to a wide range of conditions that affect a person's thoughts, emotions, behaviors and overall mental well-being. Mental health disorders that commonly occur with generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) and managing these conditions is crucial for individuals to maintain healthy relationships and improve their quality of life.
The generalized anxiety disorder market size has grown steadily in recent years. It will grow from $7.51 billion in 2023 to $7.76 billion in 2024 at a compound annual growth rate (CAGR) of 3.3%. The growth in the historic period can be attributed to mental health awareness, pharmaceutical advances, cognitive-behavioral therapy (cbt), stressful lifestyle changes. The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to $8.89 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%.
Download Free Sample Of Generalized Anxiety Disorder Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=13039&type=smp
Major players in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.
Major companies operating in the generalized anxiety disorder market are developing innovative drugs such as MM-120 and getting approval for the treatment of generalized anxiety disorder to better meet the needs of their existing consumers. Innovative drugs such as MM-120 aim to improve the management and outcomes of this mental health condition.
Read More On The Global Generalized Anxiety Disorder Market Report Here:
https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report
The Generalized Anxiety Disorder market is segmented -
1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Generalized Anxiety Disorder market.
The Business Research Company's "Global Generalized Anxiety Disorder Market Report 2024" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Generalized Anxiety Disorder Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13039
The Table Of Content For The Generalized Anxiety Disorder Market Include:
1. Executive Summary
2. Generalized Anxiety Disorder Market Characteristics
3. Generalized Anxiety Disorder Market Trends And Strategies
4. Generalized Anxiety Disorder Market - Macro Economic Scenario
5. Generalized Anxiety Disorder Market Size And Growth
.....
31. Generalized Anxiety Disorder Market Other Major And Innovative Companies
32. Global Generalized Anxiety Disorder Market Competitive Benchmarking
33. Global Generalized Anxiety Disorder Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Generalized Anxiety Disorder Market
35. Generalized Anxiety Disorder Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generalized Anxiety Disorder Market Size, Share, Trends Analysis Report 2024 | Growth Analysis By TBRC here
News-ID: 3326954 • Views: …
More Releases from The Business research company
Emerging Growth Patterns, Segment Analysis, and Competitive Approaches Influenci …
The multi-fiber push on (MPO) or mechanical transfer push-on (MTP) cabling assemblies market is on track for significant expansion in the coming years, driven by advancements in data transmission technology and increasing demand for efficient connectivity solutions. As digital transformation accelerates across industries, these cabling assemblies are becoming essential components in modern network infrastructure. Below is a detailed overview of the market's size, key drivers, leading players, trends, and main…
Analysis of Key Market Segments Driving the Microproteins Skincare Market
The microproteins skincare market is gaining significant traction as consumers increasingly seek effective, science-driven beauty solutions. With innovations in peptide technology and a growing focus on personalized skincare, this market is on a promising growth trajectory. Let's explore the current market size, leading players, influential trends, and segmentation details shaping this dynamic sector.
Projected Growth and Market Size of the Microproteins Skincare Market
The microproteins skincare market is projected to experience robust…
Market Trend Analysis: The Impact of Recent Innovations on the Medical Device Br …
The medical device brazing service market is on track for substantial growth in the coming years, driven by advancing technologies and evolving healthcare needs. As the demand for reliable and efficient medical devices rises, the brazing services that enable precision joining of components are becoming increasingly vital. Let's explore the market size projections, key players, segmentation details, and emerging trends shaping this industry.
Medical Device Brazing Service Market Size and Growth…
Segmentation, Major Trends, and Competitive Overview of the Lifestyle-Related Di …
The lifestyle-related disease supplements market is rapidly evolving as consumers become more health-conscious and proactive about managing chronic conditions linked to lifestyle choices. With an aging global population and increasing disposable incomes, this sector is set for impressive growth. Let's explore the market size, key players, trends, and segmentation that are shaping its future trajectory.
Projected Market Size and Growth Rate for Lifestyle-Related Disease Supplements
The lifestyle-related disease supplements market is on…
More Releases for Anxiety
The Anxiety Dr. Tackles Anxiety and Menopause from The Inside Out
With a non-toxic skincare product range and a meditation center, Te Sana makes wellness more attainable for American women
Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXcelSYcl5By5c5HZ4qwewxzcditBU_QOzGzI8CQiGS1PERRjp_24ch2zmAmmObvbwpb6LVSM4zlFmFZ3D0VfOBRuu2n3EojxMuhYqhLKQueRPnZjK5_OM3lHL6IPJDz7xHg40IKjQ?key=M6Cn1-UbtO5NZUXRnBaqnQ
HOUSTON - May 16, 2025 - Te Sana Wellness [https://www.tesanawellness.com/] has launched a new collection of non-toxic skincare products, empowering American women to say goodbye to overwhelming anxiety, perimenopausal, and menopausal symptoms. Launched by Dr. Lisa Cortez (The Anxiety Dr.), Te Sana Wellness is driven by a mission to offer clients…
How the Anxiety Disorders Market Is Growing in 2025 | What's New Treatments Are …
The anxiety disorders market size was valued at US$ 8.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the 7MM to reach US$ 11.9 Billion by 2035, exhibiting a growth rate (CAGR) of 3.36% during 2025-2035.
In 2025, a rapid surge is experienced in the anxiety disorders market as more and more individuals become its victims, the level of awareness, and…
Key Generalized Anxiety Disorder Market Trend for 2025-2034: Innovative Drug Dev …
"What Is the Future Outlook for the Generalized Anxiety Disorder Market's Size and Growth Rate?
The generalized anxiety disorder market will grow from $7.76 billion in 2024 to $8.01 billion in 2025, at a CAGR of 3.2%. Growth is driven by increased mental health awareness, pharmaceutical advances, the popularity of cognitive-behavioral therapy (CBT), and the stressful lifestyle changes of modern society.
The generalized anxiety disorder market is expected to reach $9.32 billion…
Social Anxiety Coach Katy Morin Announces New Resources to Help People Overcome …
Social Anxiety Antidote is a specialized platform run by Katy Morin, a dedicated Social Anxiety Coach and Certified Hypnotherapist. It offers resources and guidance for individuals struggling with social anxiety. This platform focuses on creating a safe, supportive environment where users can access personalized programs and techniques to overcome their fears and build confidence. Katy leverages her expertise to provide a path toward a more confident and less anxious life…
Anxiety and Depression Treatment Market
Anxiety and Depression Treatment Market accounted for US$ 10.89 billion in 2020 and is estimated to be US$ 13.85 billion by 2030 and is anticipated to register a CAGR of 2.7%. Anxiety and Depression are two types of mood disorders. Anxiety creates feelings of nervousness, worry or dread. Feeling of sadness, reduced energy and feeling loneliness are symptoms of Depression. Anxiety & Depression lead to chronic fatigue, tiredness & lack…
How to reduce anxiety in 2022
London, England – knus is excited to announce the launch of the 30-day anxiety plan, a free online mental health course that helps reduce anxiety. The official launch date for the 30-day anxiety plan is 1st January 2022.
The 30-day anxiety plan by knus has been designed by those with a lived experience of mental health and has shown to reduce anxiety symptoms in those that complete the plan. The…
